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Designer DNA–silica/carbon nanotube
nanocomposites for traceable and targeted
drug delivery†
Yong Hu and Christof M. Niemeyer *
Due to their unique properties like porosity, high water content, softness and biocompatibility, hydrogels
are of great interest for biomedical applications such as tissue engineering and drug delivery. We
describe a programmable drug delivery system that is based on highly biocompatible SiNP/CNT–DNA
nanocomposites, which can be synthesized in a highly modular fashion from DNA-functionalized carbon
nanotubes and silica nanoparticles via enzymatic rolling circle amplification. Specific molecular
recognition properties were implemented into the materials by DNA sequence design, as demonstrated
by incorporation of GC/CG-rich stem loop and aptamer motifs that enable selective binding of
intercalating drugs and cell surface receptors, respectively. In a proof-of-concept study we demonstrate
the utility of this approach by targeting nanocomposites loaded with the anthracycline drug doxorubicin
to HeLa cancer cells. Our observation that these designer materials work more efficiently than the pure
drug alone suggests that further developments of the concept might be useful to selectively trigger
more complex cellular pathways.
Introduction
DNA hydrogels are 3D polymeric networks that offer excellent
biocompatibility and biodegradability, tunable multifunction-
ality, stimulus reactivity, as well as unique molecular program-
mability and ability for precise molecular recognition. These
properties make DNA hydrogels a powerful material for numer-
ous applications in materials science and biomedical life
sciences.1–4 For example, DNA hydrogels are well suited for
drug release applications because specific cell binding motifs
can be conveniently integrated into the polymer backbone by
designed aptamer sequences.5 While the high water content of
synthetic hydrogels is disadvantageous for drug release appli-
cations, as this often leads to a relatively fast release kinetics,6
this problem can be overcome with DNA hydrogels, since DNA
intercalating drugs, such as the anthracycline doxorubicin
(DOX) can be bound by intercalation into CG- or GC-rich duplex
motifs of specially designed regions of the DNA backbone.5
However, in order to construct new generations of smart
hydrogel systems for drug delivery, synthetic polymers are
nowadays equipped with nanoparticles to provide the resulting
nanocomposite hydrogels with adaptable physiochemical
properties, such as mechanical, magnetic, electrical or optical
features, that cannot be achieved by the polymer backbone
alone.7
Some examples of DNA hydrogel composites have already
been described. For instance, work on DNA–carbon nanotubes
(CNT) composites shows that they have good biocompatibility8,9
and DNA–quantum dot composites have been used as traceable
and biocompatible nanomaterials for drug release.10 Further-
more, DNA hydrogel composites containing silica nanoparticles
(SiNP) have recently been used for the bottom-up assembly of
hollow spherical microstructures11 and SiNP/CNT–DNA com-
posites were used as programmable and cell-instructive
biocoatings.12 While in the latter work the outstanding attrac-
tiveness of SiNP–DNA materials for cells was used for the
adjustable adhesion of eukaryotic cells, previous work has
already shown that DNA-functionalized SiNP are not only
highly biocompatible but are also very efficiently ingested by
cells.13 This work also showed that dye-labelled SiNP are
excellently suited for traceable studies of the underlying biolo-
gical mechanisms. In view of the promising results on drug
delivery by pure DNA hydrogels,5 we therefore wanted to
investigate whether SiNP–DNA nanocomposites can also be
used for traceable drug delivery and whether a further addition
of CNT could influence the efficiency of drug delivery.
To produce the desired SiNP/CNT–DNA nanocomposite
materials, SiNP of 80 nm diameter and CNT (0.83 nm diameter,
1 mm length) were functionalized with oligonucleotide primers (P)
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and the resulting particles were used for cyclization of the
98-mer oligonucleotide T that could then serve as template for
enzymatic extension through rolling circle amplification (RCA,
Fig. 1). The subsequent addition of dNTPs and phi29 DNA
polymerase led to the formation of DNA nanocomposite net-
works, whereby either only SiNP or both SiNP and CNT were
interwoven by DNA polymers to produce binary S or ternary SC
nanocomposite materials, respectively. The same procedure
was applied for the preparation of fluorescent nanocomposites
by using Cy5-labeled core/shell SiNP,13 to yield the corres-
ponding Cy5@S and Cy5@SC materials, respectively. The nano-
composite materials were obtained as viscous hydrogels, which
could be dosed by pipetting and used for further investigations
with living cells.
Results and discussion
Characterization of the structural features of the S and SC
materials was achieved after drying by scanning electron micro-
scopy (SEM). The images revealed that that S and SC materials
have a hierarchical porous structure (Fig. 2) where the DNA
polymers wrap around and interconnect the nanoparticles
embedded in the nanocomposite materials. Ultrastructural
features like DNA polymers and individual CNT could clearly
be observed in high resolution images of the S and SC nano-
composite materials.
We initially investigated whether the SiNP–P, CNT–P, S and
SC materials are cytotoxic to HeLa cancer cells. The analysis by
a CCK-8 assay clearly showed a negligible inhibition of the
proliferation of the cancer cells and thus proved the very good
biocompatibility of the materials (Fig. S1, ESI†). The loading
capability of the nanocomposites with the anthracycline drug
doxorubicin (DOX) was then demonstrated by titration analyses
of the quenching of DOX fluorescence (Fig. 3). The fluorescence
of DOX is quenched when the drug intercalates into the DNA
backbone.10 As shown in Fig. 3c and d, the progressive decrease
in fluorescence intensity with increased amount of the
DNA nanocomposite materials was observed. The obtained
quenching spectra of SC are similar to those of S. The amount
of loaded DOX was identical for both nanocomposite materials
and was estimated in S or SC to be about 9 mg DOX per mg
material. This suggests that the added CNT do not significantly
affect drug loading of the materials, which is most likely due to the
rather low amount of CNT (80 mg mL1 in RCA reaction mixture)
Fig. 1 Synthesis of binary and ternary SiNP/CNT–DNA nanocomposite
materials. Schematic illustration of RCA-based polymerization of nano-
particles. DNA primer (P) modified nanoparticles were used for enzymatic
cyclisation of RCA template (T) and subsequent polymerization to yield the
corresponding binary (S) or ternary (SC) DNA nanocomposite materials.
Fig. 2 Scanning electron microscopy analysis of S and SC nanocompo-
site materials. Representative SEM images of S (a) and SC (b) nanocompo-
site materials at different magnifications. The right two panels of the SEM
images shown in (a) and (b) are magnifications of the red circled regions in
the corresponding left images. The arrows point at DNA polymers in (a)
and CNT in (b), respectively.
Fig. 3 Intercalation of DOX into the DNA nanocomposites. (a and b)
Schematic illustrations of DOX loading into DNA backbones of (a) S and
(b) SC, respectively. (c and d) Fluorescence quenching of DOX by different
amounts of (c) S and (d) SC at pH 7.4, respectively. Based on the titrational
analysis, the amount of drug in the DOX-saturated nanocomposites was
estimated as about 9 mg DOX per mg nanocomposite materials.
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and the fact that the CNT are tightly coated with DNA polymers,
shielding the CNT surface from the direct binding of DOX. To allow
for saturation of S or SC with the drug for the cell studies, DOX and
S/SC were mixed at pH = 7.4 and kept at room temperature for 48
hours (Fig. S2, ESI†).
To achieve efficient and selective drug delivery in tumor
cells, the RCA template was equipped not only with a drug
loading sequence, but also with an aptamer sequence. Hence,
numerous repetitions of these sequence stretches were
incorporated into the DNA backbone of the nanocomposite
materials (Fig. 4). To experimentally demonstrate the selective
cancer cell recognition and targeted drug delivery, we used a
fluorescent material DOX/Cy5@S that contained a structured
DNA backbone bearing the Sgc8 aptamer (Fig. 4a) which
specifically binds to the protein tyrosine kinase-7 (PTK7)
receptor.5,14 Initial studies with PTK7-positive HeLa cells
showed that uptake of the fluorescent Cy5@S material was
dependent on the amount of aptamer units incorporated in the
material over time during the RCA synthesis (Fig. S3, ESI†).
By virtue of double-stranded CG- or GC-rich drug association
sites, the Cy5@S or Cy5@SC materials could be used for
enrichment of intercalating drugs, such as anthracycline
DOX, thus enabling the traceable drug delivery to cells. The
nuclei of HeLa cells treated with DOX/Cy5@S (Fig. 4c) and DOX/
Cy5@SC (Fig. 4d) for 2 h displayed comparable DOX fluores-
cence signal intensities as observed for the nuclei of cells
treated with free DOX (Fig. 4b). These results suggested that
DOX molecules were successfully released intracellularly. It is
important to note that HeLa cells treated with DOX/Cy5@S or
DOX/Cy5@SC (Fig. 4c and d) revealed significantly stronger
fluorescence signals of Cy5@SiNP and DOX than cells treated
with the composite materials and free aptamer (Fig. 4e).
Following earlier work,16 the latter experiment was used as a
negative control. Typical PTK7-negative cells, such as Ramos
suspension cells,5 could not be used here because the separa-
tion of excess composite material that was not ingested is
hardly possible. The obtained results clearly indicated that
the free aptamer blocks the process of receptor-mediated
endocytosis and it is consistent with the results of cellular
uptake of the fluorescent S material (Fig. S3, ESI†). Hence, the
results conclusively show that the cellular uptake of DOX/
Cy5@S was indeed accomplished by the aptamer motifs in
the DNA backbone. After cultivation for another 24 h, the cells
exhibited a round shape and significant loss of filamentous
actin fibers, thus indicating the induction of cell apoptosis by
the ingested DOX (Fig. S5, ESI†).
Additionally, the kinetics of DOX release from the DOX/S
and DOX/SC materials were investigated in different media
(Fig. 5a–c). We found that DOX was not released from either
DOX/S or DOX/SC in PBS (pH 7.4), acetate buffer (pH 5.0) and
cell culture medium for up to 48 h at 37 1C. In contrast, DOX
was quickly released in the presence of the exonuclease DNase
I. Furthermore, the cytotoxicity of the DOX-loaded nanocompo-
sites against HeLa cells was quantified after 2 h, 24 h, and 48 h
incubation, respectively (Fig. 5d). We found that nearly all cells
were viable after 2 h of incubation, whereas cells were killed by
Fig. 4 Traceable drug delivery to PTK7-positive HeLa cells. (a) Predicted
secondary structure15 of the nanocomposite’s DNA backbone produced
by RCA. Note the presence of Sgc8 aptamer and GG/GC-rich stem loops,
designed to serve as binding sites for cells and the intercalating drug DOX,
respectively. (b–e) Representative confocal microscopy images of HeLa
cells treated with (b) free DOX, (c) DOX/Cy5@S and (d) DOX/Cy5@SC,
respectively. Note that although the images in (c) and (d) show approxi-
mately equally strong Cy5 signals, the uptake of DOX/Cy5@SC may be
slightly higher than that of DOX/Cy5@S because the CNT cause a weak
quenching of the Cy5 fluorescence signal. The cells in (e) were simulta-
neously treated with DOX/S and free Sgc8 aptamer, the latter of which
inhibited uptake of the DOX/Cy5@S material. In all cases, cells were
incubated with materials (38 mg mL1 DOX equivalent) for 2 h, washed
with PBS to remove unbound materials, fixed with PFA, and subjected to
staining of the filamentous actin with Alexa Fluor 488 Phalloidin (green) for
membrane visualization. Note that high-resolution images indicate the
localization of the Cy5-labeled DNA composites in the cellular cytoplasm
and the inner side of the cell membrane (Fig. S4, ESI†), which is in
agreement with earlier work on pure DNA hydrogels.5
Fig. 5 Time-dependent release of DOX. (a) Schematic drawing of degra-
dation and release of DOX from the composite materials. (b and c) Release
profiles of DOX from (b) DOX/S and (c) DOX/SC complexes in PBS (pH 7.4),
acetate buffer (pH 5.0), cell culture medium, and DNase I solution at 37 1C
for different times. (d) Time-dependent cytotoxicity of free DOX, DOX/S,
or DOX/SC against HeLa cells, determined after 2 h, 24 h, or 48 h
incubation, respectively.
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DOX/S or DOX/SC about 10% or 20% more effective, respec-
tively, than by free DOX after 24 h of treatment. After 48 h of
treatment, cells were killed by DOX/S or DOX/SC about 5 fold
more effectively than by free DOX. These results reflect
the efficient cellular uptake and potency of the DOX-loaded
composite materials. Interestingly, the killing efficiency of
DOX/SC was about 2 fold greater than that of DOX/S, thus
suggesting that the CNT particles contribute to the cytotoxic
efficacy of the DNA nanocomposites. This effect might stem
from CNT’s high propensity to cross cell membranes,17–19
facilitating an improved cellular uptake of the CNT-containing
nanocomposite drug delivery system (see also Fig. 4) and subse-
quently inducing increased cytotoxicity by the internalized DOX.
Altogether, the results emphasize that the novel nanocomposite
materials are well suited as vehicles for the cell-specific delivery of
DNA-binding drugs into cancer cells.
Conclusions
In summary, we describe a programmable drug delivery system
based on highly biocompatible SiNP/CNT–DNA nanocompo-
sites. These materials are available from DNA-functionalized
CNT and SiNP via enzymatic rolling circle amplification in a
highly modular synthetic procedure. Specific molecular recog-
nition properties can be easily implemented into the materials
by DNA sequence design, as demonstrated here by incorpora-
tion of GC/CG-rich stem loop and aptamer motifs that facilitate
selective binding of intercalating drugs and cell surface recep-
tors, respectively. The utility of this approach is demonstrated
in a proof-of-concept study by targeting SiNP/CNT–DNA nano-
composites loaded with the anthracycline drug DOX to HeLa
cancer cells. Given that the nanocomposites showed traceable
and targeted drug delivery along with high biocompatibility
in vitro, we believe that such systems might as well be suited for
theranostic applications in vivo. Such developments would
benefit from the use of near-infrared dyes (instead of the here
used Cy5) and they would require the systematic assessment of
e.g., the tumor uptake and excretion kinetics in higher organ-
isms. Furthermore, the observation that these designer compo-
site materials work more efficiently than the pure active
ingredients suggests that the implementation of more complex
structures, such as transmembrane receptor-activating DNA
nanostructures,20 can be harnessed to trigger more complex
cellular signaling pathways and cell fate decisions.
Experimental section
Preparation of SiNP/CNT–DNA nanocomposite materials
Two different types of DNA nanocomposites, binary S and ternary
SC materials were prepared by using SiNP (diameter 80 nm)21 and
CNT (diameter 0.83 nm, length 1 mm, Sigma-Aldrich) according to
previously reported procedures.12 Briefly, the linear ssDNA (T)
phosphorylated at the 50 end was circularized through hybridiza-
tion with P1 attached on the surface of SiNP–P using T4 DNA
ligase. To this end, linear ssDNA (T, 10 mM, 30 mL) and 10 T4 DNA
ligation buffer (500 mM Tris–HCl, 100 mM MgCl2, 10 mM ATP,
100 mM dithiothreitol (DTT), 7.5 mL) were added to 60 mL SiNP–P
suspension (10 mg mL1), and the mixture was incubated at 25 1C
for 3 h. After addition of 2.5 mL T4 DNA ligase (400 000 U mL1,
New England Biolabs), the mixture was further incubated for more
than 3 h at 25 1C to ligate the nicked ends of the template, leading
to the formation of particle–primer–template (SiNP–P–T) com-
plexes. Similarly, for preparation of the CNT–P–T, 30 mL of linear
ssDNA (T, 10 mM) and 60 mL of P2 wrapped CNT–P (200 mg mL1)
were used.
The RCA reaction mixture contained dNTPs (10 mM, 10 mL),
10 BSA (10 mg mL1, 5 mL), 10 phi29 DNA polymerase buffer
(500 mM Tris–HCl, 100 Mm MgCl2, 100 mM (NH4)2SO4, 40 mM
DTT, pH 7.5, 5 mL) and phi29 DNA polymerase (10 000 U mL1,
5 mL, New England Biolabs). The polymerisation was initiated
via the addition of 50 mL of the SiNP–P–T or the mixture of
SiNP–P–T/CNT–P–T. After incubation at 30 1C for 48 h, the
SiNP–DNA nanocomposite hydrogels or SiNP/CNT–DNA nano-
composite hydrogels were purified by carefully replacing the
reaction mixture with Dulbecco’s PBS for 5–7 times and the
nanocomposite hydrogels were stored at 4 1C before use. With a
final SiNP–P concentration of 4 mg mL1, the formed SiNP–
DNA nanocomposite hydrogel was denoted as S nanocomposite
material. In the case of mixtures containing SiNP–P (4 mg mL1)
and CNT–P (80 mg mL1), the formed SiNP/CNT–DNA nanocom-
posite hydrogel was denoted as SC nanocomposite material.
Fluorescent S and SC nanocomposite materials were prepared
using Cy5@SiNP, synthesized as previously described.13 Unless
stated otherwise, fluorescent S and SC were used for fluorescence
imaging.
DOX loading into SiNP/CNT–DNA nanocomposite materials
Doxorubicin hydrochloride (DOX, Sigma Aldrich) solution
(29 mg mL1) was incubated with the SiNP/CNT–DNA hydrogels
(63, 126, 189, 252 and 315 mg S and SC, respectively) dispersed
in 200 mL Dulbecco’s PBS (Sigma Aldrich) at room temperature
for 48 h with 250 rpm of shaking. The fluorescence quenching
spectra of DOX were reported by measuring the remaining DOX
in the supernatant using a BioTek Synergy H1 microplate
reader (Ex: 475 nm). The DOX loading amount into S or SC
materials was calculated as shown in eqn (1):
Loading amount = Total DOX amount
 DOX amount in supernatant (1)
Free unbound DOX in the supernatant was removed by
carefully replacing the supernatant with Dulbecco’s PBS for
5–7 times.
In vitro release of DOX from DOX-loaded SiNP/CNT–DNA
nanocomposite materials
In a typical drug release experiment, 315 mg of DOX/S or DOX/
SC were added to 1 mL of Dulbecco’s PBS (pH 7.4), acetate
buffer (pH 5.0), cell culture medium (Gibco Laboratories) or
DNase I solution (50 U, New England Biolabs), respectively,
and incubated with 250 rpm orbital shaking for variable times.
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The supernatant was then collected and centrifugated to
remove the particles and other aggregates. The volume of the
medium sample was maintained constant by replenishing the
corresponding solution. The concentration of released DOX
was measured by the fluorescence spectroscopy.
Cell culture
Human cervical cancer (HeLa) cells were obtained from ATCC.
The cells were cultured in 25 cm2 tissue culture flask (Corning
Inc.) with cell culture medium, comprised of EMEM, with addi-
tion of 1% penicillin/streptomycin (Thermo Fisher Scientific) and
10% FBS (Biochrom) at 37 1C in a 5% CO2 environment. The cells
were washed twice with Dulbecco’s PBS (/) (without calcium
and magnesium) and trypsinated by addition of 500 mL 0.25%
Trypsin solution (Biochrom) in PBS–EDTA (PBS with 0.02% EDTA)
for 3 min. The trypsin activity was blocked by addition of 4.5 mL
of fresh cell culture medium. The cell concentration of the
resulting suspension was determined by hemocytometer analysis.
Cytotoxicity assay
CCK-8 cell viability assay was used according to manufacturer’s
instructions to evaluate the cytotoxicity of the various compo-
site materials. In brief, HeLa cells in 200 mL medium at a
density of 8  103 cells per well were seeded into wells of a
96-well plate. After incubation at 37 1C and 5% CO2 for 12 h, the
adherent cells were incubated with 200 mL fresh medium
containing 80 mg SiNP–P, 20 mg CNT–P, 315 mg S or SC
nanocomposite materials, respectively. Cells incubated under
the same conditions in the absence of materials were used as
control. After another 24 h incubation, 20 mL CCK-8 (Dojindo) were
added to each well, and the HeLa cells were then cultivated for an
additional 4 h at 37 1C and 5% CO2. Subsequently, the absorbance
at 450 nm was recorded with a BioTek Synergy microplate reader.
Cell viability was calculated according to eqn (2):
Cell viability ¼ A1  B
A0  B
(2)
where A0 and A1 represent the OD values of CCK-8 in medium
containing HeLa cells without any treatment or after treatment
with nanocomposites, respectively. B represents the OD value of
CCK-8 in medium. Average number and standard deviation (S.D.)
were determined from five replicates of each sample.
Imaging of cells after uptake of SiNP–DNA nanocomposite
materials
To investigate the influence of aptamer formation during RCA
synthesis of the nanocomposite materials, HeLa cells were seeded
into a glass bottom 96-well plate (MoBiTec GmbH) at a density of
8  103 cells in 200 mL fresh medium and cultured at 37 1C and
5% CO2 overnight to allow the cells to adhere onto the cover slips.
The medium was then replaced with 200 mL fresh medium
containing the nanocomposite materials prepared via 0, 2, 4
and 6 h RCA reaction, respectively. After incubation at 37 1C
and 5% CO2 for 2 h, the cells were rinsed with Dulbecco’s PBS for
3 times, fixed with paraformaldehyde (PFA, 4%, Polysciences Inc.)
in Dulbecco’s PBS for 15 min. The filamentous actin was stained
with Alexa Fluor 488s phalloidin (Thermo Fisher Scientific) and
the cell nuclei were stained with 40,6-diamidino-2-phenylindole
(DAPI, Thermo Fisher Scientific). Imaging was performed using
confocal laser scanning microscopy (CLSM) on a Zeiss LSM880.
Drug delivery with DOX-loaded SiNP/CNT–DNA nanocomposite
materials
The targeted drug delivery and cytotoxicity of free DOX or DOX/
nanocomposite complexes was evaluated by using fluorescence
microscopy and CCK-8 cell viability assay, respectively. To this
end, HeLa cells were seeded into a glass bottom 96-well plate as
described above. The adhered cells were then treated with
either free DOX, DOX/S or DOX/SC (38 mg mL1 DOX equi-
valent) in cell culture medium. After incubation for 2 h, the
supernatant medium containing the materials was replaced
by fresh medium for microscopy inspection or cell viability
evaluation. For fluorescence microscopy imaging, the cells were
rinsed, fixed, stained, and imaged as described above. The
viability of HeLa cells was determined either immediately or
after cultivation for 24 h and 48 h, respectively, using CCK-8
assay as described above.
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